{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:20:54Z","timestamp":1790677254260,"version":"4.1.0"},"reference-count":222,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":89,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.csbj.2022.03.038","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T03:45:15Z","timestamp":1649043915000},"page":"2402-2414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives"],"prefix":"10.34133","volume":"20","author":[{"given":"Mengfan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0205-x"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2025-2"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/d41586-018-07276-2","article-title":"Ulcerative colitis: towards remission","volume":"563","author":"Eisenstein M.","year":"2018","unstructured":"Eisenstein M.: Ulcerative colitis: towards remission. Nature 2018; 563: S33.","journal-title":"Nature"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2002697"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.12.028"},{"key":"e_1_3_3_7_2","first-page":"9890141","article-title":"Sphingolipids as mediators in the crosstalk between microbiota and intestinal cells: implications for inflammatory bowel disease","author":"Bryan P.F.","year":"2016","unstructured":"Bryan P.F., Karla C., Edgar Alejandro M.T., Sara Elva E.P., Gemma F. et al: Sphingolipids as mediators in the crosstalk between microbiota and intestinal cells: implications for inflammatory bowel disease. Mediators Inflamm 2016; : 9890141.","journal-title":"Mediators Inflamm"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.12.015"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1237-9"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10034-5"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0306-4"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11306-014-0677-3","article-title":"Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals","volume":"11","author":"Bjerrum J.T.","year":"2015","unstructured":"Bjerrum J.T., Wang Y., Hao F., Coskun M., Ludwig C. et al: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics 2015; 11: 122.","journal-title":"Metabolomics"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s40168-021-01149-z","article-title":"A meta-analysis study of the robustness and universality of gut microbiome-metabolome associations","volume":"9","author":"Muller E.","year":"2021","unstructured":"Muller E., Algavi Y.M. and Borenstein E.: A meta-analysis study of the robustness and universality of gut microbiome-metabolome associations. Microbiome 2021; 9: 203.","journal-title":"Microbiome"},{"key":"e_1_3_3_14_2","article-title":"Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor","author":"Scott S.A.","year":"2020","unstructured":"Scott S.A., Fu J. and Chang P.V.: Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 2020; .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1242-9"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0689-3"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa262"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.06.008"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"16004","DOI":"10.1038\/npjbiofilms.2016.4","article-title":"A perspective on 16S rRNA operational taxonomic unit clustering using sequence similarity","volume":"2","author":"Nguyen N.P.","year":"2016","unstructured":"Nguyen N.P., Warnow T., Pop M. and White B.: A perspective on 16S rRNA operational taxonomic unit clustering using sequence similarity. npj Biofilms Microbiomes 2016; 2: 16004.","journal-title":"npj Biofilms Microbiomes"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08821"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1237439"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-5-r50"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.09.009"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.04.011"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2014.02.005"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","DOI":"10.1002\/mbo3.1181","article-title":"Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis","volume":"10","author":"Maldonado-Arriaga B.","year":"2021","unstructured":"Maldonado-Arriaga B., Sandoval-Jim\u00e9nez S., Rodr\u00edguez-Silverio J., Lizeth Alcar\u00e1z-Estrada S., Cort\u00e9s-Espinosa T. et al: Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis. Microbiologyopen 2021; 10: e1181.","journal-title":"Microbiologyopen"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa188"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv209"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3935"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-012520-072314"},{"key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ibd\/izaa183","article-title":"Multi-\u201c-Omics\u201d profiling in patients with quiescent inflammatory bowel disease identifies biomarkers predicting relapse","volume":"26","author":"Borren N.Z.","year":"2020","unstructured":"Borren N.Z., Plichta D., Joshi A.D., Bonilla G., Sadreyev R. et al: Multi-\u201c-Omics\u201d profiling in patients with quiescent inflammatory bowel disease identifies biomarkers predicting relapse. Inflamm Bowel Dis 2020; 26: 1524.","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.294"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2012.14"},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.chom.2007.08.002","article-title":"Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae","volume":"2","author":"Lupp C.","year":"2007","unstructured":"Lupp C., Robertson M.L., Wickham M.E., Sekirov I., Champion O.L. et al: Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2: 204.","journal-title":"Cell Host Microbe"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9040697","article-title":"The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases","volume":"9","author":"Baldelli V.","year":"2021","unstructured":"Baldelli V., Scaldaferri F., Putignani L. and Del Chierico F.: The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Microorganisms 2021; 9.","journal-title":"Microorganisms"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.09.036"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4526"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21606"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.022"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30182-4"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202100433","article-title":"Faecalibacterium prausnitzii Attenuates DSS-Induced Colitis by Inhibiting the Colonization and Pathogenicity of Candida albicans","author":"Mao X.","year":"2021","unstructured":"Mao X., Ma J., Jiao C., Tang N., Zhao X. et al: Faecalibacterium prausnitzii Attenuates DSS-Induced Colitis by Inhibiting the Colonization and Pathogenicity of Candida albicans. Mol Nutr Food Res 2021; : e2100433.","journal-title":"Mol Nutr Food Res"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312135"},{"key":"e_1_3_3_43_2","first-page":"1007","article-title":"Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response","volume":"20","author":"Luo W.","year":"2019","unstructured":"Luo W., Shen Z., Deng M., Li X., Tan B. et al: Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response. Mol Med Rep 2019; 20: 1007.","journal-title":"Mol Med Rep"},{"key":"e_1_3_3_44_2","first-page":"7567","article-title":"Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis","volume":"17","author":"Zhu C.X.","year":"2018","unstructured":"Zhu C.X., Song K.R., Shen Z.H., Quan Y.S., Tan B. et al: Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis. Mol Med Rep 2018; 17: 7567.","journal-title":"Mol Med Rep"},{"key":"e_1_3_3_45_2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bbrc.2018.05.075","article-title":"Roseburia intestinalis-derived flagellin is a negative regulator of intestinal inflammation","volume":"501","author":"Quan Y.S.","year":"2018","unstructured":"Quan Y.S., Song K.R., Zhang Y., Zhu C.X., Shen Z.H. et al: Roseburia intestinalis-derived flagellin is a negative regulator of intestinal inflammation. Biochem Biophys Res Commun 2018; 501: 791.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_3_46_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40168-021-01019-8","article-title":"Reduced metagenome sequencing for strain-resolution taxonomic profiles","volume":"9","author":"Snipen L.","year":"2021","unstructured":"Snipen L., Angell I.L., Rognes T. and Rudi K.: Reduced metagenome sequencing for strain-resolution taxonomic profiles. Microbiome 2021; 9: 79.","journal-title":"Microbiome"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0183-2"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2983-4"},{"key":"e_1_3_3_49_2","first-page":"G935","article-title":"Amount and fate of egg protein escaping assimilation in the small intestine of humans","volume":"277","author":"Evenepoel P.","year":"1999","unstructured":"Evenepoel P., Claus D., Geypens B., Hiele M., Geboes K. et al: Amount and fate of egg protein escaping assimilation in the small intestine of humans. Am J Physiol 1999; 277: G935.","journal-title":"Am J Physiol"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/4551054a"},{"key":"e_1_3_3_51_2","doi-asserted-by":"crossref","first-page":"D801","DOI":"10.1093\/nar\/gks1065","article-title":"HMDB 3.0\u2013The Human Metabolome Database in 2013","volume":"41","author":"Wishart D.S.","year":"2013","unstructured":"Wishart D.S., Jewison T., Guo A.C., Wilson M., Knox C. et al: HMDB 3.0\u2013The Human Metabolome Database in 2013. Nucleic Acids Res 2013; 41: D801.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_52_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-7172-5_13","volume-title":"Drug Safety Evaluation: Methods and Protocols","author":"Amberg A.","year":"2017","unstructured":"Amberg A., Riefke B., Schlotterbeck G., Ross A., Senn H. et al: NMR and MS Methods for Metabolomics. In: Drug Safety Evaluation: Methods and Protocols. Edited by J.-.-C. Gautier. New York, New York, NY: Springer 2017: 229."},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1039\/C1AN15605E"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.001"},{"key":"e_1_3_3_55_2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler M.","year":"2019","unstructured":"Schoeler M. and Caesar R.: Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord 2019; 20: 461.","journal-title":"Rev Endocr Metab Disord"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1177\/0148607115595980"},{"key":"e_1_3_3_57_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000228994","article-title":"Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper","volume":"55","author":"Ratnayake W.M.","year":"2009","unstructured":"Ratnayake W.M. and Galli C.: Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann Nutr Metab 2009; 55: 8.","journal-title":"Ann Nutr Metab"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.041"},{"key":"e_1_3_3_59_2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/pr060470d","article-title":"Rapid and noninvasive metabonomic characterization of inflammatory bowel disease","volume":"6","author":"Marchesi J.R.","year":"2007","unstructured":"Marchesi J.R., Holmes E., Khan F., Kochhar S., Scanlan P. et al: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007; 6: 546.","journal-title":"J Proteome Res"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304833"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18262-6"},{"key":"e_1_3_3_62_2","article-title":"IL-33 Is Involved in the Anti-Inflammatory Effects of Butyrate and Propionate on TNF\u03b1-Activated Endothelial Cells","volume":"22","author":"Li M.","year":"2021","unstructured":"Li M., van Esch B., Henricks P.A.J., Garssen J. and Folkerts G.: IL-33 Is Involved in the Anti-Inflammatory Effects of Butyrate and Propionate on TNF\u03b1-Activated Endothelial Cells. Int J Mol Sci 2021; 22.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03727-5"},{"key":"e_1_3_3_64_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases","volume":"10","author":"Parada Venegas D.","year":"2019","unstructured":"Parada Venegas D., De la Fuente M.K., Landskron G., Gonzalez M.J., Quera R. et al: Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol 2019; 10: 277.","journal-title":"Front Immunol"},{"key":"e_1_3_3_65_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1882927","article-title":"The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases","volume":"13","author":"Hosseinkhani F.","year":"2021","unstructured":"Hosseinkhani F., Heinken A., Thiele I., Lindenburg P.W., Harms A.C. et al: The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes 2021; 13: 1.","journal-title":"Gut Microbes"},{"key":"e_1_3_3_66_2","first-page":"198","article-title":"Effects of intraluminal infusion of short-chain fatty acids on the healing of colonic anastomosis in the rat","volume":"100","author":"Rolandelli R.H.","year":"1986","unstructured":"Rolandelli R.H., Koruda M.J., Settle R.G. and Rombeau J.L.: Effects of intraluminal infusion of short-chain fatty acids on the healing of colonic anastomosis in the rat. Surgery 1986; 100: 198.","journal-title":"Surgery"},{"key":"e_1_3_3_67_2","doi-asserted-by":"crossref","DOI":"10.3390\/biom11050684","article-title":"Serological Biomarkers and Diversion Colitis: Changes after Stimulation with Probiotics","volume":"11","author":"Rodr\u00edguez-Padilla \u00c1.","year":"2021","unstructured":"Rodr\u00edguez-Padilla \u00c1., Morales-Mart\u00edn G., P\u00e9rez-Quintero R., G\u00f3mez-Salgado J. and Ruiz-Frutos C.: Serological Biomarkers and Diversion Colitis: Changes after Stimulation with Probiotics. Biomolecules 2021; 11.","journal-title":"Biomolecules"},{"key":"e_1_3_3_68_2","first-page":"871","article-title":"Treatment of diversion colitis with short-chain fatty acids. Bacteriological study","volume":"19","author":"Neut C.","year":"1995","unstructured":"Neut C., Guillemot F., Gower-Rousseau C., Biron N., Cortot A. et al: Treatment of diversion colitis with short-chain fatty acids. Bacteriological study. Gastroenterol Clin Biol 1995; 19: 871.","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_3_3_69_2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5009\/gnl.2014.8.2.170","article-title":"Relationship between the severity of diversion colitis and the composition of colonic bacteria: a prospective study","volume":"8","author":"Baek S.J.","year":"2014","unstructured":"Baek S.J., Kim S.H., Lee C.K., Roh K.H., Keum B. et al: Relationship between the severity of diversion colitis and the composition of colonic bacteria: a prospective study. Gut Liver 2014; 8: 170.","journal-title":"Gut Liver"},{"key":"e_1_3_3_70_2","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3748\/wjg.v24.i16.1734","article-title":"Diversion colitis and pouchitis: A mini-review","volume":"24","author":"Tominaga K.","year":"2018","unstructured":"Tominaga K., Kamimura K., Takahashi K., Yokoyama J., Yamagiwa S. et al: Diversion colitis and pouchitis: A mini-review. World J Gastroenterol 2018; 24: 1734.","journal-title":"World J Gastroenterol"},{"key":"e_1_3_3_71_2","article-title":"Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis","volume":"25","author":"Tominaga K.","year":"2021","unstructured":"Tominaga K., Tsuchiya A., Mizusawa T., Matsumoto A., Minemura A. et al: Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis. Biochem Biophys Rep 2021; 25: 100892.","journal-title":"Biochem Biophys Rep"},{"key":"e_1_3_3_72_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.dld.2015.09.005","article-title":"Effect of butyrate enemas on gene expression profiles and endoscopic\/histopathological scores of diverted colorectal mucosa: A randomized trial","volume":"48","author":"Luceri C.","year":"2016","unstructured":"Luceri C., Femia A.P., Fazi M., Di Martino C., Zolfanelli F. et al: Effect of butyrate enemas on gene expression profiles and endoscopic\/histopathological scores of diverted colorectal mucosa: A randomized trial. Dig Liver Dis 2016; 48: 27.","journal-title":"Dig Liver Dis"},{"key":"e_1_3_3_73_2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12664-015-0577-0","article-title":"Diversion proctocolitis and response to treatment with short-chain fatty acids\u2013a clinicopathological study in children","volume":"34","author":"Pal K.","year":"2015","unstructured":"Pal K., Tinalal S., Al Buainain H. and Singh V.P.: Diversion proctocolitis and response to treatment with short-chain fatty acids\u2013a clinicopathological study in children. Indian J Gastroenterol 2015; 34: 292.","journal-title":"Indian J Gastroenterol"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306423"},{"key":"e_1_3_3_75_2","first-page":"262","article-title":"The potential of metabolic and lipid profiling in inflammatory bowel diseases: A pilot study","volume":"20","author":"Tefas C.","year":"2020","unstructured":"Tefas C., Ciobanu L., Tan\u021b\u0103u M., Moraru C. and Socaciu C.: The potential of metabolic and lipid profiling in inflammatory bowel diseases: A pilot study. Bosn J Basic Med Sci 2020; 20: 262.","journal-title":"Bosn J Basic Med Sci"},{"key":"e_1_3_3_76_2","first-page":"8495913","article-title":"The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease","volume":"2019","author":"Ma C.","year":"2019","unstructured":"Ma C., Vasu R. and Zhang H.: The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease. Mediators Inflamm 2019; 2019: 8495913.","journal-title":"Mediators Inflamm"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2021.111448"},{"key":"e_1_3_3_78_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbrc.2017.06.032","article-title":"N-3 polyunsaturated fatty acid-enriched lipid emulsion improves Paneth cell function via the IL-22\/Stat3 pathway in a mouse model of total parenteral nutrition","volume":"490","author":"Wang J.","year":"2017","unstructured":"Wang J., Tian F., Zheng H., Tian H., Wang P. et al: N-3 polyunsaturated fatty acid-enriched lipid emulsion improves Paneth cell function via the IL-22\/Stat3 pathway in a mouse model of total parenteral nutrition. Biochem Biophys Res Commun 2017; 490: 253.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321173"},{"key":"e_1_3_3_80_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.trsl.2021.03.016","article-title":"Long-chain monounsaturated fatty acids improve endothelial function with altering microbial flora","volume":"237","author":"Tsutsumi R.","year":"2021","unstructured":"Tsutsumi R., Yamasaki Y., Takeo J., Miyahara H., Sebe M. et al: Long-chain monounsaturated fatty acids improve endothelial function with altering microbial flora. Transl Res 2021; 237: 16.","journal-title":"Transl Res"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6927com"},{"key":"e_1_3_3_82_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031238","article-title":"Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR \u03b3 to suppress colitis","volume":"7","author":"Bassaganya-Riera J.","year":"2012","unstructured":"Bassaganya-Riera J., Viladomiu M., Pedragosa M., De Simone C., Carbo A. et al: Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR \u03b3 to suppress colitis. PLoS ONE 2012; 7: e31238.","journal-title":"PLoS ONE"},{"key":"e_1_3_3_83_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jdermsci.2013.10.010","article-title":"Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid","volume":"73","author":"Huang W.C.","year":"2014","unstructured":"Huang W.C., Tsai T.H., Chuang L.T., Li Y.Y., Zouboulis C.C. et al: Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid. J Dermatol Sci 2014; 73: 232.","journal-title":"J Dermatol Sci"},{"key":"e_1_3_3_84_2","article-title":"Lauric acid ameliorates lipopolysaccharide (LPS)-induced liver inflammation by mediating TLR4\/MyD88 pathway in Sprague Dawley (SD) rats","volume":"265","author":"Khan H.U.","year":"2021","unstructured":"Khan H.U., Aamir K., Jusuf P.R., Sethi G., Sisinthy S.P. et al: Lauric acid ameliorates lipopolysaccharide (LPS)-induced liver inflammation by mediating TLR4\/MyD88 pathway in Sprague Dawley (SD) rats. Life Sci 2021; 265.","journal-title":"Life Sci"},{"key":"e_1_3_3_85_2","first-page":"223","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease, Nature Reviews","volume":"17","author":"Lavelle A.","year":"2020","unstructured":"Lavelle A. and Sokol H.: Gut microbiota-derived metabolites as key actors in inflammatory bowel disease, Nature Reviews. Gastroenterology & Hepatology 2020; 17: 223.","journal-title":"Gastroenterology & Hepatology"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05470-4"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00430-8"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.08.028"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4102"},{"key":"e_1_3_3_90_2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.aah5825","article-title":"Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8alphaalpha(+) T cells","volume":"357","author":"Cervantes-Barragan L.","year":"2017","unstructured":"Cervantes-Barragan L., Chai J.N., Tianero M.D., Di Luccia B., Ahern P.P. et al: Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8alphaalpha(+) T cells. Science 2017; 357: 806.","journal-title":"Science"},{"key":"e_1_3_3_91_2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127551","article-title":"Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22-dependent manner","volume":"5","author":"Busbee P.B.","year":"2020","unstructured":"Busbee P.B., Menzel L., Alrafas H.R., Dopkins N., Becker W. et al: Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22-dependent manner. JCI Insight 2020; 5.","journal-title":"JCI Insight"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.08.003"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.79"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000790"},{"key":"e_1_3_3_95_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11306-017-1311-y","article-title":"Alterations in lipid, amino acid, and energy metabolism distinguish crohn's disease from ulcerative colitis and control subjects by serum metabolomic profiling","volume":"14","author":"Scoville E.A.","year":"2018","unstructured":"Scoville E.A., Allaman M.M., Brown C.T., Motley A.K., Horst S.N. et al: Alterations in lipid, amino acid, and energy metabolism distinguish crohn's disease from ulcerative colitis and control subjects by serum metabolomic profiling. Metabolomics 2018; 14: 17.","journal-title":"Metabolomics"},{"key":"e_1_3_3_96_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051641","article-title":"Transcriptional and metabolomic analysis of l-arginine\/nitric oxide pathway in inflammatory bowel disease and its association with local inflammatory and angiogenic response: preliminary findings","volume":"21","author":"Krzystek-Korpacka M.","year":"2020","unstructured":"Krzystek-Korpacka M., Fleszar M.G., Bednarz-Misa I., Lewandowski \u0141., Szczuka I. et al: Transcriptional and metabolomic analysis of l-arginine\/nitric oxide pathway in inflammatory bowel disease and its association with local inflammatory and angiogenic response: preliminary findings. Int J Mol Sci 2020; 21.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2015.03.006"},{"key":"e_1_3_3_98_2","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1172\/JCI126923","article-title":"Arginase impedes the resolution of colitis by altering the microbiome and metabolome","volume":"130","author":"Baier J.","year":"2020","unstructured":"Baier J., Gansbauer M., Giessler C., Arnold H., Muske M. et al: Arginase impedes the resolution of colitis by altering the microbiome and metabolome. J Clin Invest 2020; 130: 5703.","journal-title":"J Clin Invest"},{"key":"e_1_3_3_99_2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/0148607115581374","article-title":"Pretreatment and Treatment With L-Arginine Attenuate Weight Loss and Bacterial Translocation in Dextran Sulfate Sodium Colitis","volume":"40","author":"Andrade M.E.","year":"2016","unstructured":"Andrade M.E., Santos R.D., Soares A.D., Costa K.A., Fernandes S.O. et al: Pretreatment and Treatment With L-Arginine Attenuate Weight Loss and Bacterial Translocation in Dextran Sulfate Sodium Colitis. JPEN J Parenter Enteral Nutr 2016; 40: 1131.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-120419-015419"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2007.tb03887.x"},{"key":"e_1_3_3_102_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnut.2019.00016","article-title":"Polyamines and Gut Microbiota","volume":"6","author":"Tofalo R.","year":"2019","unstructured":"Tofalo R., Cocchi S. and Suzzi G.: Polyamines and Gut Microbiota. Front Nutr 2019; 6: 16.","journal-title":"Front Nutr"},{"key":"e_1_3_3_103_2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/acs.jafc.0c07095","article-title":"Preventive and therapeutic spermidine treatment attenuates acute colitis in mice","volume":"69","author":"Ma L.","year":"2021","unstructured":"Ma L., Ni L., Yang T., Mao P., Huang X. et al: Preventive and therapeutic spermidine treatment attenuates acute colitis in mice. J Agric Food Chem 2021; 69: 1864.","journal-title":"J Agric Food Chem"},{"key":"e_1_3_3_104_2","first-page":"1","article-title":"Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice","volume":"12","author":"Ma L.","year":"2020","unstructured":"Ma L., Ni Y., Wang Z., Tu W., Ni L. et al: Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut Microbes 2020; 12: 1.","journal-title":"Gut Microbes"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.2001.280.5.G992"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1080\/713609209"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.037"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22212-1"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.07.003"},{"key":"e_1_3_3_110_2","first-page":"321","article-title":"Faecal and serum metabolomics in paediatric inflammatory bowel disease","volume":"11","author":"Kolho K.L.","year":"2017","unstructured":"Kolho K.L., Pessia A., Jaakkola T., de Vos W.M. and Velagapudi V.: Faecal and serum metabolomics in paediatric inflammatory bowel disease. J Crohns Colitis 2017; 11: 321.","journal-title":"J Crohns Colitis"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.07.020"},{"key":"e_1_3_3_112_2","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8040082","article-title":"Untargeted metabolomics of extracts from faecal samples demonstrates distinct differences between paediatric crohn's disease patients and healthy controls but no significant changes resulting from exclusive enteral nutrition treatment","volume":"8","author":"Alghamdi A.","year":"2018","unstructured":"Alghamdi A., Gerasimidis K., Blackburn G., Akinci D., Edwards C. et al: Untargeted metabolomics of extracts from faecal samples demonstrates distinct differences between paediatric crohn's disease patients and healthy controls but no significant changes resulting from exclusive enteral nutrition treatment. Metabolites 2018; 8.","journal-title":"Metabolites"},{"key":"e_1_3_3_113_2","doi-asserted-by":"crossref","first-page":"18879","DOI":"10.1038\/s41598-020-75306-z","article-title":"Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease","volume":"10","author":"Diederen K.","year":"2020","unstructured":"Diederen K., Li J.V., Donachie G.E., de Meij T.G., de Waart D.R. et al: Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease. Sci Rep 2020; 10: 18879.","journal-title":"Sci Rep"},{"key":"e_1_3_3_114_2","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13911","article-title":"A 12-month pilot study outcomes of vagus nerve stimulation in Crohn's disease","volume":"32","author":"Sinniger V.","year":"2020","unstructured":"Sinniger V., Pellissier S., Fauvelle F., Trocm\u00e9 C., Hoffmann D. et al: A 12-month pilot study outcomes of vagus nerve stimulation in Crohn's disease. Neurogastroenterol Motil 2020; 32: e13911.","journal-title":"Neurogastroenterol Motil"},{"key":"e_1_3_3_115_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4899-0117-0_37","article-title":"Taurine can ameliorate inflammatory bowel disease in rats","author":"Son M.","year":"1998","unstructured":"Son M., Ko J.I., Kim W.B., Kang H.K. and Kim B.K.: Taurine can ameliorate inflammatory bowel disease in rats. Taurine 3: Cell Regul Mech 1998; : 291.","journal-title":"Taurine 3: Cell Regul Mech"},{"key":"e_1_3_3_116_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF02975370","article-title":"Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats","volume":"21","author":"Son M.W.","year":"1998","unstructured":"Son M.W., Ko J.I., Doh H.M., Kim W.B., Park T.S. et al: Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats. Arch Pharmacal Res 1998; 21: 531.","journal-title":"Arch Pharmacal Res"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-007-0562-8"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.10.048"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.12.011"},{"key":"e_1_3_3_120_2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132055","article-title":"A human-origin probiotic cocktail ameliorates aging-related leaky gut and inflammation via modulating the microbiota\/taurine\/tight junction axis","volume":"5","author":"Ahmadi S.","year":"2020","unstructured":"Ahmadi S., Wang S., Nagpal R., Wang B., Jain S. et al: A human-origin probiotic cocktail ameliorates aging-related leaky gut and inflammation via modulating the microbiota\/taurine\/tight junction axis. JCI Insight 2020; 5.","journal-title":"JCI Insight"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i24.3609"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302578"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.01.021"},{"key":"e_1_3_3_124_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40168-019-0740-4","article-title":"Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids","volume":"7","author":"Wang S.","year":"2019","unstructured":"Wang S., Martins R., Sullivan M.C., Friedman E.S., Misic A.M. et al: Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids. Microbiome 2019; 7: 126.","journal-title":"Microbiome"},{"key":"e_1_3_3_125_2","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00045-20","article-title":"Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids","volume":"88","author":"Winston J.A.","year":"2020","unstructured":"Winston J.A., Rivera A.J., Cai J., Thanissery R., Montgomery S.A. et al: Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids. Infect Immun 2020; 88.","journal-title":"Infect Immun"},{"key":"e_1_3_3_126_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105767","article-title":"Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism","volume":"171","author":"Dong S.","year":"2021","unstructured":"Dong S., Zhu M., Wang K., Zhao X., Hu L. et al: Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism. Pharmacol Res 2021; 171: 105767.","journal-title":"Pharmacol Res"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa007"},{"key":"e_1_3_3_128_2","first-page":"6645970","article-title":"Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer","volume":"2021","author":"Liu L.","year":"2021","unstructured":"Liu L., Yang M., Dong W., Liu T., Song X. et al: Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer. Gastroenterol Res Pract 2021; 2021: 6645970.","journal-title":"Gastroenterol Res Pract"},{"key":"e_1_3_3_129_2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s12864-019-5899-3","article-title":"Metagenomic analysis of bile salt biotransformation in the human gut microbiome","volume":"20","author":"Das P.","year":"2019","unstructured":"Das P., Marcisauskas S., Ji B. and Nielsen J.: Metagenomic analysis of bile salt biotransformation in the human gut microbiome. BMC Genomics 2019; 20: 517.","journal-title":"BMC Genomics"},{"key":"e_1_3_3_130_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1865708","article-title":"Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease","volume":"13","author":"Wang Y.","year":"2021","unstructured":"Wang Y., Gao X., Zhang X., Xiao F., Hu H. et al: Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease. Gut Microbes 2021; 13: 1.","journal-title":"Gut Microbes"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.212159"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00256.2016"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14456"},{"key":"e_1_3_3_134_2","doi-asserted-by":"crossref","first-page":"G378","DOI":"10.1152\/ajpgi.00435.2016","article-title":"The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing","volume":"314","author":"Mroz M.S.","year":"2018","unstructured":"Mroz M.S., Lajczak N.K., Goggins B.J., Keely S. and Keely S.J.: The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing. Am J Physiol Gastrointest Liver Physiol 2018; 314: G378.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i9.923"},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06208-3"},{"key":"e_1_3_3_137_2","article-title":"Mass spectrometry-based metabolomics in microbiome investigations","author":"Bauermeister A.","year":"2021","unstructured":"Bauermeister A., Mannochio-Russo H., Costa-Lotufo L.V., Jarmusch A.K. and Dorrestein P.C.: Mass spectrometry-based metabolomics in microbiome investigations. Nat Rev Microbiol 2021; .","journal-title":"Nat Rev Microbiol"},{"key":"e_1_3_3_138_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0616-3"},{"key":"e_1_3_3_139_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03707-9"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.11.028"},{"key":"e_1_3_3_141_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40168-021-01199-3","article-title":"Performance determinants of unsupervised clustering methods for microbiome data","volume":"10","author":"Shi Y.","year":"2022","unstructured":"Shi Y., Zhang L., Peterson C.B., Do K.A. and Jenq R.R.: Performance determinants of unsupervised clustering methods for microbiome data. Microbiome 2022; 10: 25.","journal-title":"Microbiome"},{"key":"e_1_3_3_142_2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1039\/D1NP00023C","article-title":"Advances in decomposing complex metabolite mixtures using substructure- and network-based computational metabolomics approaches","volume":"38","author":"Beniddir M.A.","year":"2021","unstructured":"Beniddir M.A., Kang K.B., Genta-Jouve G., Huber F., Rogers S. et al: Advances in decomposing complex metabolite mixtures using substructure- and network-based computational metabolomics approaches. Nat Prod Rep 2021; 38: 1967.","journal-title":"Nat Prod Rep"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01213-8"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2020.10.005"},{"key":"e_1_3_3_145_2","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gky466","article-title":"PaintOmics 3: a web resource for the pathway analysis and visualization of multi-omics data","volume":"46","author":"Hern\u00e1ndez-de-Diego R.","year":"2018","unstructured":"Hern\u00e1ndez-de-Diego R., Tarazona S., Mart\u00ednez-Mira C., Balzano-Nogueira L., Furi\u00f3-Tar\u00ed P. et al: PaintOmics 3: a web resource for the pathway analysis and visualization of multi-omics data. Nucleic Acids Res 2018; 46: W503.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321106"},{"key":"e_1_3_3_147_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.024"},{"key":"e_1_3_3_148_2","first-page":"25877","article-title":"Manipulating the gut microbiota to maintain health and treat disease","volume":"26","author":"Scott K.P.","year":"2015","unstructured":"Scott K.P., Antoine J.M., Midtvedt T. and van Hemert S.: Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis 2015; 26: 25877.","journal-title":"Microb Ecol Health Dis"},{"key":"e_1_3_3_149_2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3748\/wjg.v22.i3.1078","article-title":"Role of antibiotics for treatment of inflammatory bowel disease","volume":"22","author":"Nitzan O.","year":"2016","unstructured":"Nitzan O., Elias M., Peretz A. and Saliba W.: Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol 2016; 22: 1078.","journal-title":"World J Gastroenterol"},{"key":"e_1_3_3_150_2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j2083","article-title":"Diagnosis and management of inflammatory bowel disease in children","volume":"357","author":"Oliveira S.B.","year":"2017","unstructured":"Oliveira S.B. and Monteiro I.M.: Diagnosis and management of inflammatory bowel disease in children. BMJ 2017; 357: j2083.","journal-title":"BMJ"},{"key":"e_1_3_3_151_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1751-2980.12216","article-title":"Use of antibiotics in patients with Crohn's disease: a systematic review and meta-analysis","volume":"16","author":"Su J.W.","year":"2015","unstructured":"Su J.W., Ma J.J. and Zhang H.J.: Use of antibiotics in patients with Crohn's disease: a systematic review and meta-analysis. J Dig Dis 2015; 16: 58.","journal-title":"J Dig Dis"},{"key":"e_1_3_3_152_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2036.1990.tb00456.x","article-title":"The efficacy of tobramycin in the treatment of ulcerative colitis","volume":"4","author":"Burke D.A.","year":"1990","unstructured":"Burke D.A., Axon A.T., Clayden S.A., Dixon M.F., Johnston D. et al: The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1990; 4: 123.","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_3_3_153_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041623","article-title":"Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease","volume":"22","author":"Banfi D.","year":"2021","unstructured":"Banfi D., Moro E., Bosi A., Bistoletti M., Cerantola S. et al: Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease. Int J Mol Sci 2021; 22.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_3_154_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312297"},{"key":"e_1_3_3_155_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050649","article-title":"Impact of prematurity and perinatal antibiotics on the developing intestinal microbiota: a functional inference study","volume":"17","author":"Arboleya S.","year":"2016","unstructured":"Arboleya S., S\u00e1nchez B., Sol\u00eds G., Fern\u00e1ndez N., Su\u00e1rez M. et al: Impact of prematurity and perinatal antibiotics on the developing intestinal microbiota: a functional inference study. Int J Mol Sci 2016; 17.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_3_156_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-019-10165-x"},{"key":"e_1_3_3_157_2","doi-asserted-by":"crossref","DOI":"10.3390\/nu13082814","article-title":"Bifidobacterium animalis subsp. lactis BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome","volume":"13","author":"Merenstein D.","year":"2021","unstructured":"Merenstein D., Fraser C.M., Roberts R.F., Liu T., Grant-Beurmann S. et al: Bifidobacterium animalis subsp. lactis BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome. Nutrients 2021; 13.","journal-title":"Nutrients"},{"key":"e_1_3_3_158_2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10050959","article-title":"Repeated fecal microbial transplantations and antibiotic pre-treatment are linked to improved clinical response and remission in inflammatory bowel disease: a systematic review and pooled proportion meta-analysis","volume":"10","author":"Mocanu V.","year":"2021","unstructured":"Mocanu V., Rajaruban S., Dang J., Kung J.Y., Deehan E.C. et al: Repeated fecal microbial transplantations and antibiotic pre-treatment are linked to improved clinical response and remission in inflammatory bowel disease: a systematic review and pooled proportion meta-analysis. J Clin Med 2021; 10.","journal-title":"J Clin Med"},{"key":"e_1_3_3_159_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103293","article-title":"Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?","volume":"66","author":"Deleu S.","year":"2021","unstructured":"Deleu S., Machiels K., Raes J., Verbeke K. and Vermeire S.: Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?. EBioMedicine 2021; 66: 103293.","journal-title":"EBioMedicine"},{"key":"e_1_3_3_160_2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ecco-jcc\/jjz064","article-title":"Butyrate does not protect against inflammation-induced loss of epithelial barrier function and cytokine production in primary cell monolayers from patients with ulcerative colitis","volume":"13","author":"Vancamelbeke M.","year":"2019","unstructured":"Vancamelbeke M., Laeremans T., Vanhove W., Arnauts K., Ramalho A.S. et al: Butyrate does not protect against inflammation-induced loss of epithelial barrier function and cytokine production in primary cell monolayers from patients with ulcerative colitis. J Crohns Colitis 2019; 13: 1351.","journal-title":"J Crohns Colitis"},{"key":"e_1_3_3_161_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.05.026"},{"key":"e_1_3_3_162_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01115-9"},{"key":"e_1_3_3_163_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b09125"},{"key":"e_1_3_3_164_2","article-title":"Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial","author":"Sarbagili Shabat C.","year":"2021","unstructured":"Sarbagili Shabat C., Scaldaferri F., Zittan E., Hirsch A., Mentella M.C. et al: Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial. J Crohns Colitis 2021; .","journal-title":"J Crohns Colitis"},{"key":"e_1_3_3_165_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0173-3"},{"key":"e_1_3_3_166_2","first-page":"2032","article-title":"Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis, Microb","volume":"13","author":"Chen P.","year":"2020","unstructured":"Chen P., Xu H., Tang H., Zhao F., Yang C. et al: Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis, Microb. Biotechnol 2020; 13: 2032.","journal-title":"Biotechnol"},{"key":"e_1_3_3_167_2","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3389\/fmicb.2017.01889","article-title":"Emerging Trends in \u201cSmart Probiotics\u201d: Functional Consideration for the Development of Novel Health and Industrial Applications","volume":"8","author":"El Hage R.","year":"2017","unstructured":"El Hage R., Hernandez-Sanabria E. and Van de Wiele T.: Emerging Trends in \u201cSmart Probiotics\u201d: Functional Consideration for the Development of Novel Health and Industrial Applications. Front Microbiol 2017; 8: 1889.","journal-title":"Front Microbiol"},{"key":"e_1_3_3_168_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000440815.76627.64"},{"key":"e_1_3_3_169_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804812105"},{"key":"e_1_3_3_170_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1826748","article-title":"Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3","volume":"12","author":"Lenoir M.","year":"2020","unstructured":"Lenoir M., Mart\u00edn R., Torres-Maravilla E., Chadi S., Gonz\u00e1lez-D\u00e1vila P. et al: Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3. Gut Microbes 2020; 12: 1.","journal-title":"Gut Microbes"},{"key":"e_1_3_3_171_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0495-2"},{"key":"e_1_3_3_172_2","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00730-21","article-title":"Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation","author":"Qu S.","year":"2021","unstructured":"Qu S., Fan L., Qi Y., Xu C., Hu Y. et al: Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation. Microbiol Spectr 2021; : e0073021.","journal-title":"Microbiol Spectr"},{"key":"e_1_3_3_173_2","article-title":"Akkermansia muciniphilaA purified membrane protein from or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 T cells in mice","author":"Wang L.","year":"2020","unstructured":"Wang L., Tang L., Feng Y., Zhao S., Han M. et al: Akkermansia muciniphilaA purified membrane protein from or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 T cells in mice. Gut 2020; .","journal-title":"Gut"},{"key":"e_1_3_3_174_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00239"},{"key":"e_1_3_3_175_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-021-11453-1"},{"key":"e_1_3_3_176_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113863"},{"key":"e_1_3_3_177_2","first-page":"5580","article-title":"for the delivery of matrix-tethered therapeutic domains to the gut","volume":"10","author":"Praveschotinunt P.","year":"1917","unstructured":"Praveschotinunt P., Duraj-Thatte A.M., Gelfat I., Bahl F., Chou D.B., Engineered E. et al: for the delivery of matrix-tethered therapeutic domains to the gut. Nat Commun 1917; 10: 5580.","journal-title":"Nat Commun"},{"key":"e_1_3_3_178_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00760-2"},{"key":"e_1_3_3_179_2","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10219","article-title":"An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae\/butyrate\/retinoic acid axis","volume":"6","author":"Wang L.","year":"2021","unstructured":"Wang L., Liao Y., Yang R., Zhu Z., Zhang L. et al: An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae\/butyrate\/retinoic acid axis. Bioeng Transl Med 2021; 6: e10219.","journal-title":"Bioeng Transl Med"},{"key":"e_1_3_3_180_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.75"},{"key":"e_1_3_3_181_2","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1007\/s00394-021-02503-5","article-title":"Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis","volume":"60","author":"Zhang X.F.","year":"2021","unstructured":"Zhang X.F., Guan X.X., Tang Y.J., Sun J.F., Wang X.K. et al: Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis. Eur J Nutr 2021; 60: 2855.","journal-title":"Eur J Nutr"},{"key":"e_1_3_3_182_2","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2012.24","article-title":"Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial","volume":"4","author":"De Preter V.","year":"2013","unstructured":"De Preter V., Joossens M., Ballet V., Shkedy Z., Rutgeerts P. et al: Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial. Clin Transl Gastroenterol 2013; 4: e30.","journal-title":"Clin Transl Gastroenterol"},{"key":"e_1_3_3_183_2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1046\/j.1365-2036.1998.00432.x","article-title":"Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study","volume":"12","author":"Mitsuyama K.","year":"1998","unstructured":"Mitsuyama K., Saiki T., Kanauchi O., Iwanaga T., Tomiyasu N. et al: Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study. Aliment Pharmacol Ther 1998; 12: 1225.","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_3_3_184_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00054725-200303000-00005","article-title":"Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study","volume":"9","author":"Hallert C.","year":"2003","unstructured":"Hallert C., Bj\u00f6rck I., Nyman M., Pousette A., Gr\u00e4nn\u00f6 C. et al: Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis 2003; 9: 116.","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_3_3_185_2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/19490976.2018.1526583","article-title":"Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels","volume":"10","author":"Valcheva R.","year":"2019","unstructured":"Valcheva R., Koleva P., Mart\u00ednez I., Walter J., G\u00e4nzle M.G. et al: Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels. Gut Microbes 2019; 10: 334.","journal-title":"Gut Microbes"},{"key":"e_1_3_3_186_2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/gutjnl-2011-300413","article-title":"Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial","volume":"61","author":"Joossens M.","year":"2012","unstructured":"Joossens M., De Preter V., Ballet V., Verbeke K., Rutgeerts P. et al: Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial. Gut 2012; 61: 958.","journal-title":"Gut"},{"key":"e_1_3_3_187_2","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.3389\/fimmu.2019.02979","article-title":"Dietary Fiber Pectin Ameliorates Experimental Colitis in a Neutral Sugar Side Chain-Dependent Manner","volume":"10","author":"Ishisono K.","year":"2019","unstructured":"Ishisono K., Mano T., Yabe T. and Kitaguchi K.: Dietary Fiber Pectin Ameliorates Experimental Colitis in a Neutral Sugar Side Chain-Dependent Manner. Front Immunol 2019; 10: 2979.","journal-title":"Front Immunol"},{"key":"e_1_3_3_188_2","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1021\/jf103262s","article-title":"Dietary pectin regulates the levels of inflammatory cytokines and immunoglobulins in interleukin-10 knockout mice","volume":"58","author":"Ye M.B.","year":"2010","unstructured":"Ye M.B. and Lim B.O.: Dietary pectin regulates the levels of inflammatory cytokines and immunoglobulins in interleukin-10 knockout mice. J Agric Food Chem 2010; 58: 11281.","journal-title":"J Agric Food Chem"},{"key":"e_1_3_3_189_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12866-016-0869-2","article-title":"Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora","volume":"16","author":"Wei Y.","year":"2016","unstructured":"Wei Y., Gong J., Zhu W., Tian H., Ding C. et al: Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora. BMC Microbiol 2016; 16: 255.","journal-title":"BMC Microbiol"},{"key":"e_1_3_3_190_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.11.030"},{"key":"e_1_3_3_191_2","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1039\/C9FO01537J","article-title":"Dietary cranberry suppressed colonic inflammation and alleviated gut microbiota dysbiosis in dextran sodium sulfate-treated mice","volume":"10","author":"Cai X.","year":"2019","unstructured":"Cai X., Han Y., Gu M., Song M., Wu X. et al: Dietary cranberry suppressed colonic inflammation and alleviated gut microbiota dysbiosis in dextran sodium sulfate-treated mice. Food Funct 2019; 10: 6331.","journal-title":"Food Funct"},{"key":"e_1_3_3_192_2","first-page":"1","article-title":"Prebiotic effects of goji berry in protection against inflammatory bowel disease","author":"Sun Q.","year":"2022","unstructured":"Sun Q., Du M., Kang Y. and Zhu M.J.: Prebiotic effects of goji berry in protection against inflammatory bowel disease. Crit Rev Food Sci Nutr 2022; : 1.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"e_1_3_3_193_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06090-z"},{"key":"e_1_3_3_194_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15818"},{"key":"e_1_3_3_195_2","first-page":"1420","article-title":"Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised","volume":"11","author":"Cox S.R.","year":"2017","unstructured":"Cox S.R., Prince A.C., Myers C.E., Irving P.M., Lindsay J.O. et al: Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised. Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial, J Crohns Colitis 2017; 11: 1420.","journal-title":"Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial, J Crohns Colitis"},{"key":"e_1_3_3_196_2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.gastro.2019.09.024","article-title":"Effects of Low FODMAP Diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial","volume":"158","author":"Cox S.R.","year":"2020","unstructured":"Cox S.R., Lindsay J.O., Fromentin S., Stagg A.J., McCarthy N.E. et al: Effects of Low FODMAP Diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology 2020; 158: 176.","journal-title":"Gastroenterology"},{"key":"e_1_3_3_197_2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1053\/j.gastro.2021.05.047","article-title":"A Randomized trial comparing the specific carbohydrate diet to a mediterranean diet in adults with Crohn's disease","volume":"161","author":"Lewis J.D.","year":"2021","unstructured":"Lewis J.D., Sandler R.S., Brotherton C., Brensinger C., Li H. et al: A Randomized trial comparing the specific carbohydrate diet to a mediterranean diet in adults with Crohn's disease. Gastroenterology 2021; 161: 837.","journal-title":"Gastroenterology"},{"key":"e_1_3_3_198_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0344-2"},{"key":"e_1_3_3_199_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1854640","article-title":"Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis","volume":"12","author":"Green J.E.","year":"2020","unstructured":"Green J.E., Davis J.A., Berk M., Hair C., Loughman A. et al: Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis. Gut Microbes 2020; 12: 1.","journal-title":"Gut Microbes"},{"key":"e_1_3_3_200_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17077"},{"key":"e_1_3_3_201_2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ecco-jcc\/jjy031","article-title":"Effect of faecal microbiota transplantation for treatment of clostridium difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis of cohort studies","volume":"12","author":"Chen T.","year":"2018","unstructured":"Chen T., Zhou Q., Zhang D., Jiang F., Wu J. et al: Effect of faecal microbiota transplantation for treatment of clostridium difficile infection in patients with inflammatory bowel disease: a systematic review and meta-analysis of cohort studies. J Crohns Colitis 2018; 12: 710.","journal-title":"J Crohns Colitis"},{"key":"e_1_3_3_202_2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/apt.13969","article-title":"Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy","volume":"45","author":"Jiang Z.D.","year":"2017","unstructured":"Jiang Z.D., Ajami N.J., Petrosino J.F., Jun G., Hanis C.L. et al: Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy. Aliment Pharmacol Ther 2017; 45: 899.","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_3_3_203_2","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","article-title":"Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent clostridium difficile infection","volume":"156","author":"Hvas C.L.","year":"2019","unstructured":"Hvas C.L., Dahl J\u00f8rgensen S.M., J\u00f8rgensen S.P., Storgaard M., Lemming L. et al: Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent clostridium difficile infection. Gastroenterology 2019; 156: 1324.","journal-title":"Gastroenterology"},{"key":"e_1_3_3_204_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31266-8"},{"key":"e_1_3_3_205_2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis","volume":"149","author":"Rossen N.G.","year":"2015","unstructured":"Rossen N.G., Fuentes S., van der Spek M.J., Tijssen J.G., Hartman J.H. et al: Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology 2015; 149: 110.","journal-title":"Gastroenterology"},{"key":"e_1_3_3_206_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.001"},{"key":"e_1_3_3_207_2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello S.P.","year":"2019","unstructured":"Costello S.P., Hughes P.A., Waters O., Bryant R.V., Vincent A.D. et al: Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA 2019; 321: 156.","journal-title":"JAMA"},{"key":"e_1_3_3_208_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.001"},{"key":"e_1_3_3_209_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.257"},{"key":"e_1_3_3_210_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.crohns.2013.10.002","article-title":"Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection","volume":"8","author":"Quera R.","year":"2014","unstructured":"Quera R., Espinoza R., Estay C. and Rivera D.: Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J Crohns Colitis 2014; 8: 252.","journal-title":"J Crohns Colitis"},{"key":"e_1_3_3_211_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12727"},{"key":"e_1_3_3_212_2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ibd\/izz223","article-title":"Alternative and complementary approaches for the treatment of inflammatory bowel disease: evidence from cochrane reviews","volume":"26","author":"Chande N.","year":"2020","unstructured":"Chande N., Costello S.P., Limketkai B.N., Parker C.E., Nguyen T.M. et al: Alternative and complementary approaches for the treatment of inflammatory bowel disease: evidence from cochrane reviews. Inflamm Bowel Dis 2020; 26: 843.","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_3_3_213_2","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2021-0167"},{"key":"e_1_3_3_214_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.10.001"},{"key":"e_1_3_3_215_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.11.024"},{"key":"e_1_3_3_216_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215927110"},{"key":"e_1_3_3_217_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041942","article-title":"Nanoparticles in the Food Industry and Their Impact on Human Gut Microbiome and Diseases","volume":"22","author":"Ghebretatios M.","year":"2021","unstructured":"Ghebretatios M., Schaly S. and Prakash S.: Nanoparticles in the Food Industry and Their Impact on Human Gut Microbiome and Diseases. Int J Mol Sci 2021; 22.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_3_218_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-019-0462-9"},{"key":"e_1_3_3_219_2","article-title":"Integration of spatial and single-cell transcriptomic data elucidates mouse organogenesis","author":"Lohoff T.","year":"2021","unstructured":"Lohoff T., Ghazanfar S., Missarova A., Koulena N., Pierson N. et al: Integration of spatial and single-cell transcriptomic data elucidates mouse organogenesis. Nat Biotechnol 2021; .","journal-title":"Nat Biotechnol"},{"key":"e_1_3_3_220_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1065-y"},{"key":"e_1_3_3_221_2","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12795"},{"key":"e_1_3_3_222_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309940"},{"key":"e_1_3_3_223_2","first-page":"750","article-title":"A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients, Cell Mol","volume":"2","author":"Jacobs J.P.","year":"2016","unstructured":"Jacobs J.P., Goudarzi M., Singh N., Tong M., McHardy I.H. et al: A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients, Cell Mol. Gastroenterol Hepatol 2016; 2: 750.","journal-title":"Gastroenterol Hepatol"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022001131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022001131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2022.03.038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:54:47Z","timestamp":1779022487000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2022.03.038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":222,"alternative-id":["10.1016\/j.csbj.2022.03.038"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2022.03.038","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2022.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}